Home
About
Publications Trends
Recent Publications
Expert Search
Archive
immunohistochemistry (ihc)
What Are the Applications of IHC in Cancer?
IHC is widely used in cancer to:
Diagnose and classify tumors
Determine the tissue of origin for metastatic cancers
Assess prognostic and predictive biomarkers
Guide treatment decisions based on protein expression
Frequently asked queries:
What is Immunohistochemistry (IHC)?
How Does IHC Work?
What Are the Applications of IHC in Cancer?
Why is IHC Important in Cancer Diagnosis?
What Are Some Common Markers Used in IHC for Cancer?
What Are the Advantages of IHC?
What Are the Limitations of IHC?
How is IHC Evolving with Technological Advances?
What is the Impact of Isoflavones on Breast Cancer?
What is the Link Between Trans Fats and Cancer?
What is the Role of Estrogen Receptors?
How is Data Collected for Cancer Audits?
How Can Lifestyle Changes Help?
Do side effects vary between different types of cancer treatments?
What Laws Protect Sensitive Data?
Why are Stents Used in Cancer Treatment?
What Research Is Being Done in This Area?
What Is the Recovery Process Like?
Which Types of Cancer Can Be Treated with IORT?
Can Caffeine Affect Cancer Treatment?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe